Vinita Kailasanath has extensive experience in strategic intellectual property and data-driven transactions in life sciences and technology, and particularly at their intersection. She has represented life sciences companies, technology companies, healthcare companies and providers, and investors in connection with the execution of their cutting-edge MedTech and digital health strategies in addition to their other complex licenses and collaborations, strategic investments, and R&D and supply agreements. Ms. Kailasanath has advised clients on transactions involving medical devices (including SaMD), wearables, mobile apps, telemedicine, artificial intelligence/machine learning, software, hardware, pharmaceutical products and biologics. Vinita also routinely advises on the intellectual property aspects of mergers, acquisitions and joint ventures.

Ms. Kailasanath’s work across the life sciences and technology sectors makes her uniquely well-equipped to structure a wide variety of agreements to enable clients to develop, use, commercialize and protect innovative MedTech offerings. In doing so, she draws on her graduate degree in molecular and cellular biology and in-depth knowledge of intellectual property gained through a clerkship at the Court of Appeals for the Federal Circuit. She is well-versed in the business, regulatory environment, and goals of the healthcare sector, while also being deeply familiar with Software as-a-Service (“SaaS”), Infrastructure-as-a-Service (“IaaS”) and Platform-as-a-Service (“PaaS”) arrangements as well as other cloud and technology-related considerations.